Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial

Gottlieb, RL; Nirula, A; Chen, P; Boscia, J; Heller, B; Morris, J; Huhn, G; Cardona, J; Mocherla, B; Stosor, V; Shawa, I; Kumar, P; Adams, AC; Van Naarden, J; Custer, KL; Durante, M; Oakley, G; Schade, AE; Holzer, TR; Ebert, PJ; Higgs, RE; Kallewaard, NL; Sabo, J; Patel, DR; Klekotka, P; Shen, L; Skovronsky, DM

Skovronsky, DM (corresponding author), Eli Lilly & Co, 893 Delaware St, Indianapolis, IN 46225 USA.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021; 325 (7): 632

Abstract

IMPORTANCE Coronavirus disease 2019 (COVID-19) continues to spread rapidly worldwide. Neutralizing antibodies are a potential treatment for COVID-19. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索